Acknowledgments
ALS Canada/Brain Canada, FRQS, LHS, NSERC
Acknowledgments
This study was supported by the “Deutsche Gesellschaft für Muskelkranke e.V.”.
Acknowledgments
ALS Association, Department of Defense (DOD) foundation, Academy of Finland and business Finland provided funding for this study.
Acknowledgments
Funding from the ALSA Milton Safenowitz Postdoctoral Fellowship and the U.S.A. DOD
Acknowledgments
Funding was provided by the MND Association. The authors declare no conflicts of interest.
Acknowledgments
This work is supported by the Association Française contre les Myopathies (AFM), the Association Institut de Myologie (AIM), the Sorbonne University (SU), the Institut National de la Santé et de la Recherche Médicale (INSERM), and the Thierry Latran Foundation.
Acknowledgments
Packards Center, Vanier Canada, ALS Canada and CIHR
Acknowledgments
Funding sources: University of Helsinki, Academy of Finland, Jane and Aatos Erkko Foundation, Finnish Cultural Foundation, The Ella and Georg Ehrnrooth Foundation, Department of Defense, USA
Acknowledgments
Funding for this work was from NH and MRC Grant APP1104299 (Turner, Rogers), and MNDRIA GIA Charcot Grant 1848 (Rogers).
Acknowledgments
ALS patients and families, the Lewis family fund, AHW, and NIH GM119544
Acknowledgments
Les Turner ALS Foundation
Acknowledgments
D.W. was supported by grants from the “Portfolio Technology and Medicine” and the Helmholtz-Validierungsfonds of the “Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft” and also by the Technology Transfer Fund of the Forschungßentrum Jülich. K.-J.L. and D.W. were supported by “Portfolio Drug Research” of the “Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft”.
Declaration of interest: The authors declare no conflicts of interest.
Acknowledgments
This work was supported by the ALS Association and a Department of Defense Therapeutic Idea Award.
Acknowledgments
Wyss Center, Campus Biotech, Geneva, Switzerland.
Acknowledgments
This work was supported by Project ALS.
Acknowledgments
The project is financially supported by Brain Canada and ALS Canada.
Acknowledgments
ALSA 17-IIP-343, DoD Award nr. W81XWH-17-1-0036 to MP.
Acknowledgments
Supported by Institut Pasteur de Montevideo, ANII and ABScience. We are grateful to our ALS patients who donated their post-mortem muscle tissues to advance ALS research. OH is a cofounder/shareholder of ABScience.
Acknowledgments
This study was funded by the Research Grant from Motor Neuron Disease Association to VLB (Buchman/Apr13/822-791). Transgenic mice were received from the IPAC RAS collection supported by Federal Agency for Scientific Organizations program for support the bioresource collections No. 0090-2017-0016 and Russian Science Foundation grant № 18-15-00357.
Acknowledgments
This study was funded by Telethon Grant GGP14025 to M.N. (2014–2017); Thierry Latran Foundation to SC and EH, EU Joint Programme for Neurodegenerative Disease (JPND; 529-2014-7500) to SC and EH
Acknowledgments
Aberdeen University and ERASMUS
Acknowledgments
The authors thank the authors of studies selected for this review who also helped recover missing data. The authors also want to thank Gold Coast University Hospital Librarians, especially Sarah Thorning, for their assistance in conducting literature search.
Acknowledgments
We acknowledge the Sigrid Juselius Foundation, NHMRC, ARC, Motor Neurone Disease Research Institute of Australia (Betty Laidlaw MND Grant), and the Victorian Brain Bank Network for supporting our research.
Acknowledgments
We acknowledge the Sigrid Juselius Foundation, NHMRC, ARC, Motor Neurone Disease Research Institute of Australia (Betty Laidlaw MND Grant), Fight MND (Translational Research Project), and the Victorian Brain Bank Network for supporting our research.
Acknowledgments
Funded by the NHMRC, the Motor Neurone Disease Research Institute of Australia (Betty Laidlaw MND Grant), and Fight MND.
Acknowledgments
The current study is funded by the German Federal Ministry of Education and Research (BMBF, Project GO-Bio).